Trade Moderna Inc ^MRNA

AlphaQuest LLC Buys 13,096 Shares of Moderna, Inc. $MRNA - Markets Daily

Moderna said revenue would grow in 2026 for the first time since 2021, says Jim Cramer

Pfizer News | Markets Insider

Merck News | Markets Insider

Moderna Again Fails to Shift Most Covid-Shot Patent Costs to US

Option traders moderately bearish in Moderna with shares down 3.89% | Markets Insider

Moderna reverses lower after court issues memo in patent fight with Arbutus | Markets Insider

Moderna rises after Delaware court issues memo in patent fight with Arbutus | Markets Insider

Moderna, Inc.'s (NASDAQ:MRNA) Price Is Right But Growth Is Lacking After Shares Rocket 43% - Simply Wall St News

Moderna VP and regulatory expert moves to private practice

Moderna Rare Disease Deal And Leadership Shift Raise Valuation Questions

Mitsubishi UFJ Trust & Banking Corp Makes New $2.35 Million Investment in Moderna, Inc. $MRNA - Markets Daily

91,010 Shares in Moderna, Inc. $MRNA Purchased by Mitsubishi UFJ Trust & Banking Corp

Privium Fund Management B.V. Lowers Holdings in Moderna, Inc. $MRNA

Moderna's Chief Medical Officer Jacqueline Miller Resigns as Company Shifts Focus, ETPharma

Biotech Stocks To Follow Today - January 30th - Stock Observer

Moderna CMO Jacqueline Miller to step down

Universal Beteiligungs und Servicegesellschaft mbH Has $2.06 Million Holdings in Moderna, Inc. $MRNA - Daily Political

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927) | Morningstar

Jim Cramer on Moderna: "We Have to Wait and See"

Moderna Shifts Vaccine Funding Approach And Expands mRNA Oncology Ambitions

Moderna (NASDAQ:MRNA) Coverage Initiated at Barclays

CNN.com - Transcripts

Assessing Moderna (MRNA) Valuation After Promising Melanoma Vaccine Data With Keytruda

Moderna Recasts Growth Story Toward Oncology As Vaccine Prospects Blur

Why Moderna (MRNA) Is Up 16.4% After Five-Year Data On Personalized Melanoma mRNA Therapy

Up 73% year to date, this stock in my SIPP is suddenly on fire!

Moderna, Inc. $MRNA Shares Sold by Baillie Gifford & Co.

Moderna downsizing investments in late-stage vaccine trials amid U.S. skepticism - CBS News

Moderna (NASDAQ:MRNA) Hits New 1-Year High - Time to Buy? - Markets Daily

Stocks making the biggest moves midday: FTNT, MRNA, INTC, BHC

Moderna Melanoma Vaccine Data Reshapes mRNA Outlook And Investor Focus

Merck Weighs mRNA Breakthrough And Revolution Deal Against Oncology Valuation

Moderna (NASDAQ:MRNA) Shares Gap Down - Here's What Happened - Daily Political

Baseline characteristics in Moderna cancer vaccine 'misleading': Leerink's Dr. Mani Foroohar

Moderna (NASDAQ:MRNA) Trading Up 10.2% - Time to Buy?

Stock market today: Dow, S&P 500, Nasdaq rise for second day in a row as Greenland drama fades

Moderna (NASDAQ:MRNA) Trading Up 10.2% - Here's What Happened - Stock Observer

Moderna Curbing Investment in Vaccine Trials Due to US Backlash

Moderna (MRNA) Touches 52-Week High on Strong Clinical Results

FTSE 100 LIVE: Stocks climb as Trump cancels European tariffs amid 'framework' Greenland deal

Moderna Cancer Vaccine Data Extends Oncology Potential Beyond Covid Franchise

Moderna, Inc. (NASDAQ:MRNA) Receives Average Recommendation of "Reduce" from Brokerages - Markets Daily

Trending tickers: AMD, Intel, Moderna, Associated British Foods and Young & Co's Brewery

10 Big Names Leaving Wall Street Behind; 7 Are Hitting Record Highs

Moderna Stock Rallies as Oncology Results Improve the Platform's Value Case | Investing.com NG

Moderna Stock Rallies as Oncology Results Improve the Platform's Value Case | Investing.com

Moderna (NASDAQ:MRNA) Sets New 1-Year High - What's Next?

Moderna Pops 17%-Is There Life in MRNA, Down 90% from COVID High? | Investing.com

Promising vaccine for aggressive melanoma could unlock the body's potential to fight cancer | Euronews

Sumitomo Mitsui Trust Group Inc. Reduces Position in Moderna, Inc. $MRNA

Moderna Cancer Data Sparks Questions On Oncology Pivot And Stock Valuation

Sugar Maple Asset Management LLC Buys Shares of 17,000 Moderna, Inc. $MRNA - Stock Observer

Moderna, Merck's skin cancer vaccine shows sustained benefit in five-year follow-up

Bernstein Sticks to Their Hold Rating for AbbVie (ABBV) | Markets Insider

Pfizer (PFE) Receives a Hold from Bernstein | Markets Insider

Bernstein Remains a Hold on Moderna (MRNA) | Markets Insider

Health Care Down, But not by Much, on Defensive Bias - Health Care Roundup | Morningstar

Dow Jones Top Company Headlines at 11 AM ET: Moderna, Merck Report Positive Results From Cancer-Vaccine Study | D.R. ... | Morningstar

Moderna shares up 2% as skin cancer vaccine shows sustained benefit in five-year follow-up - The Economic Times

Dow Jones Top Company Headlines at 9 AM ET: Warner Strikes New All-Cash Deal With Netflix | Moderna, ... | Morningstar

Dow Jones Top Company Headlines at 7 AM ET: Moderna, Merck Report Positive Results From Cancer-Vaccine Study | GSK ... | Morningstar

Correction to Moderna, Merck Cancer-Vaccine Story | Morningstar

Intismeran Autogene + KEYTRUDA Improves 5-Year Recurrence-Free Survival In Melanoma, Moderna & Merck

Health: Moderna, Merck's skin cancer vaccine shows sustained benefit in long-term follow-up

European Patent Office ruling 'clear win' for Moderna, says Citi | Markets Insider

Analysts Conflicted on These Healthcare Names: Rapport Therapeutics, Inc. (RAPP) and Moderna (MRNA) | Markets Insider

Arbutus says European patent revoked by European Patent Office | Markets Insider

Moderna (MRNA) Valuation Check After Raised 2025 Outlook And Cost Cuts At JPMorgan Conference

MRNA: Late Stage Vaccine Outcomes Will Define Future Upside Potential

Moderna, Inc. (NASDAQ:MRNA) Given Average Rating of "Reduce" by Analysts

Moderna (NASDAQ:MRNA) Upgraded at Wall Street Zen

I Hope Moderna (MRNA) Posts Growth, Says Jim Cramer

Moderna (NASDAQ:MRNA) Shares Gap Up - Still a Buy?

Arbutus Biopharma Shares Fall 19% On European Patent Revocation

Moderna (NASDAQ:MRNA) Stock Price Up 7.1% - Here's What Happened - Markets Daily

Moderna Forecasts $1.9 Billion Sales for 2025 Amid COVID Vaccine Decline, ETPharma

Analysts Set Expectations for Moderna FY2030 Earnings - Daily Political

Moderna (MRNA) Valuation Check After Upgraded 2025 Outlook And Pipeline Update At J.P. Morgan Conference

Best Biotech Stocks To Keep An Eye On - January 14th - Markets Daily

Moderna (MRNA) Stock: Biotech Leader Surges 30% on Updated Guidance

Moderna (MRNA) Rockets 17% on Strong Preliminary FY25 Results

Trending tickers: Nvidia, Intel, Moderna, BP and Vistry

Adobe stock downgraded, Moderna surges on upbeat guidance

Moderna (NASDAQ:MRNA) Shares Up 7.1% - Still a Buy?

Moderna (NASDAQ:MRNA) Trading 7.1% Higher - Here's Why - Stock Observer

Moderna Chair Says US Assault on Science Is Just Beginning (3)

Biotech Stocks To Add to Your Watchlist - January 11th - Stock Observer

Top Biotech Stocks To Research - January 10th - Stock Observer

Promising Biotech Stocks To Keep An Eye On - January 9th - Stock Observer

Moderna (MRNA) Is Up 14.8% After Advancing Its mRNA Flu Vaccine Toward Regulatory Approvals

Monsanto Sues COVID-19 Vaccine Manufacturers, Alleging Copyright Infringement | ZeroHedge

Fostering innovation through experimentation

Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach | Malay Mail